Sanofi India Q1 net profit rises to Rs 146 crore

Sanofi India Q1 net profit rises to Rs 146 crore

Revenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration. It was Rs 784.5 crore for the same period a year ago, Sanofi India said in a regulatory filing

Advertisement
Revenue from operations of the company stood at Rs 725.1 crore for the quarter under considerationRevenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration
PTI
  • Apr 27, 2021,
  • Updated Apr 27, 2021 10:29 PM IST

Drug firm Sanofi India on Tuesday reported a net profit of Rs 145.9 crore for the March ended quarter.

The company had posted a net profit of Rs 85.4 crore for the corresponding period of the previous fiscal, Sanofi India said in a regulatory filing.

Advertisement

Revenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration. It was Rs 784.5 crore for the same period a year ago, it added.

"Sale performance for the quarter ended March 31, 2021, is not comparable with the quarter ended March 31, 2020, due to lower export sales on account of transfer of Ankleshwar manufacturing facility during the previous year," Sanofi India said.

Shares of Sanofi India closed at Rs 7,479.65 per scrip on BSE, up 0.55 per cent from its previous close.

Also Read: Sanofi's COVID-19 vaccine not ready in 2021, says CEO

Drug firm Sanofi India on Tuesday reported a net profit of Rs 145.9 crore for the March ended quarter.

The company had posted a net profit of Rs 85.4 crore for the corresponding period of the previous fiscal, Sanofi India said in a regulatory filing.

Advertisement

Revenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration. It was Rs 784.5 crore for the same period a year ago, it added.

"Sale performance for the quarter ended March 31, 2021, is not comparable with the quarter ended March 31, 2020, due to lower export sales on account of transfer of Ankleshwar manufacturing facility during the previous year," Sanofi India said.

Shares of Sanofi India closed at Rs 7,479.65 per scrip on BSE, up 0.55 per cent from its previous close.

Also Read: Sanofi's COVID-19 vaccine not ready in 2021, says CEO

Read more!
Advertisement